Teva Pharmaceutical Industries Ltd ADR (TEVA) | |||
---|---|---|---|
11.03 0.34 (3.18%) | 08-08 16:00 | ||
Open: | 10.86 | Pre. Close: | 10.69 |
High: | 11.05 | Low: | 10.805 |
Volume: | 20,185,751 | Market Cap: | 12,249M |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 11.057 - 11.089 | 11.089 - 11.126 |
Low: | 10.71 - 10.75 | 10.75 - 10.795 |
Close: | 10.959 - 11.02 | 11.02 - 11.088 |
Stock Technical Analysis | |
---|---|
Overall: | ![]() |
Target: | Six months: 12.91 ![]() One year: 15.07 ![]() |
Support: | Support1: 8.41 ![]() Support2: 6.78 |
Resistance: | Resistance1: 11.05 ![]() Resistance2: 12.91 ![]() |
Pivot: | 8.81 ![]() |
Moving Averages: | MA(5): 10.33 ![]() MA(20): 8.36 ![]() MA(100): 8.54 ![]() MA(250): 8.71 ![]() |
MACD: | MACD(12,26): 0.77 ![]() Signal(12,26,9): 0.42 ![]() |
%K %D: | %K(14,3): 99.09 ![]() %D(3): 98.45 ![]() |
RSI: | RSI(14): 81.97 ![]() |
52-Week: | High: 11.05 Low: 6.78 Change(%): 13.2 |
Average Vol(K): | 3-Month: 13355 10-Days: 25756 |
Price, MAs and Bollinger Bands |
---|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TEVA ] has closed below upper band by 10.6%. Bollinger Bands are 168.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue. |
Stock chart |
---|
![]() |
Financial Analysis | |
---|---|
Price to Book Value: | Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
Price to Earnings: | Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
Discounted cash flow: | Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
Return on Assets: | Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
Return on Equity: | Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
Debt to Equity: | Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Stock Basics & Statistics | |
---|---|
Exchange: New York Stock Exchange | |
Sector: Healthcare | |
Industry: Drug Manufacturers—Specialty & Generic | |
Shares Out. (M) | 1100.00 |
Shares Float (M) | 1100.00 |
% Held by Insiders | 1.50 |
% Held by Institutions | 46.25 |
Shares Short (K) | 17760 |
Shares Short Prior Month (K) | 19380 |
Stock Financials | |
---|---|
EPS | 0.660 |
Book Value (p.s.) | 9.490 |
Profit Margin | -6.83 |
Operating Margin | 18.87 |
Return on Assets (ttm) | 3.8 |
Return on Equity (ttm) | -10.0 |
Qtrly Rev. Growth | -3.2 |
Gross Profit (p.s.) | 6.900 |
Sales Per Share | 14.027 |
EBITDA (p.s.) | 3.855 |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | 1060.00 |
Levered Free Cash Flow (M) | 2540.00 |
Stock Valuation | |
---|---|
PE Ratio | 16.71 |
PEG Ratio | |
Price to Book value | 1.16 |
Price to Sales | 0.79 |
Price to Cash Flow | 11.45 |
Stock Dividends | |
---|---|
Dividend | |
Dividend Yield | |
Dividend Growth |